| ORIGINAL ARTICLE |
|
| Year : 2022 | Volume
: 24
| Issue : 1 | Page : 30-36 |
|
|
Clinicoepidemiological profile of COVID-19-positive migrant population and their outcomes: A multicentric, retrospective study from Northeast India
Joydeep Ghosh1, Amit Kumar Das2, Manasa Shettisara Janney3
1 Department of Surgery, Military Hospital, Dimapur, Nagaland, India
2 Department of Pathology and Laboratory Medicine, INHS Asvini, Mumbai, Maharashtra, India
3 Department of Dermatology, Military Hospital, Dimapur, Nagaland, India
Correspondence Address:
(Dr) Manasa Shettisara Janney
Medical Officer, Department of Dermatology, Military Hospital, Dimapur - 797 112, Nagaland
India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/jmms.jmms_42_21
|
|
|
Introduction: Emergence of a novel coronavirus disease (COVID 19) and its subsequent spread to India lead to declaration of lockdown by the government in various phases to reduce the transmission of COVID 19. Northeastern India being relatively remote had its first case relatively late. Later, with incoming migrant population, there was a surge in cases. This study aims to determine the clinicoepidemiological characteristics and outcomes in COVID 19 positive migrant population treated at multiple centers in Northeast India. Methods: This is a retrospective, cross-sectional,multicentric study. Data were collected from case sheets of 198 COVID-19 positive patients treated at designated COVID-19 hospitals in Northeast India. Results: Independent t-test and Fisher's exact test were used. P<0.05 was considered statistically significant. Majority of the study population were between 31 and 50 years (62.1%) with overall male preponderance (94.9%). Nearly one third (31.8%) of the study population gave a history of contact. Fever was seen 92.4% of patients. Majority (97.0%) of the study population had mild to moderate disease and only 3.0% were severely diseased/critically ill. 30%, 7%, and 3% of the study population received oxygen support, noninvasive ventilation, and ventilator support, respectively. Only 1.5% of the study population had complications of acute respiratory distress syndrome, shock, and sepsis, and the mortality rate was 1.1%. The average duration of hospitalization was 14.17 ± 5.48 days, and the average time taken to become COVID negative by reverse transcription polymerase chain reaction was 37.93 ± 7.54 days. Conclusion: A large number of COVID-positive patients had mild-to-moderate course of disease. Fever was the most common symptom. Around one-third of patients required respiratory support. Rate of complications and mortality were low in the study population. Presence of comorbidities, "O" blood group, abnormal X ray findings, elevated levels of C reactive protein, D dimer, and erythrocyte sedimentation rate had a significant positive association with severity. |
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
